AngioDynamics rises on US FDA clearance of prostate cancer treatment device

AngioDynamics

09/12/2024 11:47

** Shares of medical device maker AngioDynamics  ANGO.O 
rise 12.6% to $7.88 premarket
    ** ANGO says the U.S. FDA has cleared its medical device to
treat prostate cancer
    ** The device, called NanoKnife System, uses electrical
pulses to destroy cancer cells by creating tiny holes in their
membranes
    ** Prostate cancer affects 1.5 mln men annually worldwide -
ANGO
    ** As of last close, stock has fallen 10.7% YTD

 (Reporting by Kamal Choudhury in Bengaluru)
 ((Kamal.Choudhury@thomsonreuters.com;))